{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T05:08:28Z","timestamp":1786597708119,"version":"build-2736575974"},"reference-count":121,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031543","name":"Association of British Neurologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000627","name":"Guarantors of Brain","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000317","name":"Action Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000317","id-type":"DOI","asserted-by":"publisher"}]},{"name":"British Paediatric Neurology Association"},{"DOI":"10.13039\/501100004218","name":"Patrick Berthoud Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003343","name":"Cambridge Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000381","name":"Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>One of the most promising strategies to delay, prevent, or reverse disability progression in multiple sclerosis is enhancing endogenous remyelination. While preclinical research has established a strong connection between ageing and remyelination failure, evidence for this same link in people with multiple sclerosis remains less secure. As clinical trials for remyelinating therapies progress, clarifying this relationship is essential. A deeper understanding could guide the selection of therapeutic candidates, refine patient selection, and optimize the timing of treatment delivery.<\/jats:p>\n                  <jats:p>In this review, we describe the available evidence that has investigated the impact of age on remyelination in people with multiple sclerosis. We categorize these into pathological, imaging and clinical studies. We explore the challenges in measuring remyelination in humans and determine the implications for the connection between remyelination and age.<\/jats:p>\n                  <jats:p>Current evidence suggests that there is reduced capacity for remyelination with advancing age in people with multiple sclerosis. However, these findings are at times inconsistent, and the precise contribution of ageing to remyelination failure is unclear. There does not appear to be an age cut-off beyond which remyelination is not possible, as there are pathological data supporting remyelination occurring, to some extent, across all ages. Interestingly, the impact of age may vary by lesion location. Further targeted research, specifically exploring the relationship between ageing and remyelination, is needed. With emerging evidence that ageing processes might be malleable, we conclude that targeting the biology of ageing might also be an important strategy to therapeutically enhance remyelination.<\/jats:p>","DOI":"10.1093\/brain\/awaf373","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:59:51Z","timestamp":1759406391000},"page":"48-58","source":"Crossref","is-referenced-by-count":6,"title":["Ageing and remyelination failure in people with multiple sclerosis"],"prefix":"10.1093","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4058-0030","authenticated-orcid":false,"given":"Trisha","family":"Mukherjee","sequence":"first","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8710-0930","authenticated-orcid":false,"given":"Christopher E","family":"McMurran","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathon","family":"Holland","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Daruwalla","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gioia","family":"Riboni-Verri","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7737-5834","authenticated-orcid":false,"given":"J William L","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J M","family":"Franklin","sequence":"additional","affiliation":[{"name":"Altos Labs\u2014Cambridge Institute of Science, Granta Park , Cambridge CB21 6GQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4738-0760","authenticated-orcid":false,"given":"Alasdair","family":"Coles","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7562-2838","authenticated-orcid":false,"given":"Nick G","family":"Cunniffe","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"2026010812432020800_awaf373-B1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00415-019-09421-x","article-title":"Promoting remyelination in multiple sclerosis","volume":"268","author":"Cunniffe","year":"2021","journal-title":"J Neurol"},{"key":"2026010812432020800_awaf373-B2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrn.2017.136","article-title":"Regenerating CNS myelin\u2014From mechanisms to experimental medicines","volume":"18","author":"Franklin","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"2026010812432020800_awaf373-B3","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1177\/1352458519884006","article-title":"Remyelination and ageing: Reversing the ravages of time","volume":"25","author":"Neumann","year":"2019","journal-title":"Mult Scler"},{"key":"2026010812432020800_awaf373-B4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.mcn.2003.10.014","article-title":"Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination","volume":"25","author":"Woodruff","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"2026010812432020800_awaf373-B5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.stem.2019.08.015","article-title":"Metformin restores CNS remyelination capacity by rejuvenating aged stem cells","volume":"25","author":"Neumann","year":"2019","journal-title":"Cell Stem Cell"},{"key":"2026010812432020800_awaf373-B6","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nn.3469","article-title":"M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination","volume":"16","author":"Miron","year":"2013","journal-title":"Nat Neurosci"},{"key":"2026010812432020800_awaf373-B7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.stem.2011.11.019","article-title":"Rejuvenation of regeneration in the aging central nervous system","volume":"10","author":"Ruckh","year":"2012","journal-title":"Cell Stem Cell"},{"key":"2026010812432020800_awaf373-B8","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/s43587-021-00109-4","article-title":"Myc determines the functional age state of oligodendrocyte progenitor cells","volume":"1","author":"Neumann","year":"2021","journal-title":"Nat Aging"},{"key":"2026010812432020800_awaf373-B9","doi-asserted-by":"crossref","first-page":"a040907","DOI":"10.1101\/cshperspect.a040907","article-title":"Regeneration, rejuvenation, and replacement: Turning back the clock on tissue aging","volume":"13","author":"Rando","year":"2021","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2026010812432020800_awaf373-B10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev."},{"key":"2026010812432020800_awaf373-B11","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/brain\/88.5.937","article-title":"Electron microscopic features of multiple sclerosis lesions.","volume":"88","author":"P\u00e9rier","year":"1965","journal-title":"Brain"},{"key":"2026010812432020800_awaf373-B12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.stem.2020.03.017","article-title":"Problems and pitfalls of identifying remyelination in multiple sclerosis","volume":"26","author":"Neumann","year":"2020","journal-title":"Cell Stem Cell"},{"key":"2026010812432020800_awaf373-B13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ana.410050105","article-title":"Remyelination in multiple sclerosis","volume":"5","author":"Prineas","year":"1979","journal-title":"Ann Neurol"},{"key":"2026010812432020800_awaf373-B14","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2990.2011.01189.x","article-title":"Review: The architecture of inflammatory demyelinating lesions: Implications for studies on pathogenesis","volume":"37","author":"Lassmann","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2026010812432020800_awaf373-B15","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1212\/01.CON.0000433291.23091.65","article-title":"Pathology of multiple sclerosis: Where do we stand?","volume":"19","author":"Popescu","year":"2013","journal-title":"Continuum (Minneap Minn)"},{"key":"2026010812432020800_awaf373-B16","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ana.24497","article-title":"Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque","volume":"78","author":"Frischer","year":"2015","journal-title":"Ann Neurol"},{"key":"2026010812432020800_awaf373-B17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn917","article-title":"Why does remyelination fail in multiple sclerosis?","volume":"3","author":"Franklin","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"2026010812432020800_awaf373-B18","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181a8260a","article-title":"Remyelination capacity of the MS brain decreases with disease chronicity","volume":"72","author":"Goldschmidt","year":"2009","journal-title":"Neurology"},{"key":"2026010812432020800_awaf373-B19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/brain\/awf031","article-title":"Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord","volume":"125","author":"Wolswijk","year":"2002","journal-title":"Brain"},{"key":"2026010812432020800_awaf373-B20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJMoa010994","article-title":"Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis","volume":"346","author":"Chang","year":"2002","journal-title":"N Engl J Med."},{"key":"2026010812432020800_awaf373-B21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/brain\/123.1.105","article-title":"Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis","volume":"123","author":"Wolswijk","year":"2000","journal-title":"Brain"},{"key":"2026010812432020800_awaf373-B22","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/brain\/awl217","article-title":"Remyelination is extensive in a subset of multiple sclerosis patients","volume":"129","author":"Patrikios","year":"2006","journal-title":"Brain"},{"key":"2026010812432020800_awaf373-B23","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/brain\/awn096","article-title":"Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis","volume":"131","author":"Kuhlmann","year":"2008","journal-title":"Brain"},{"key":"2026010812432020800_awaf373-B24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00005072-199305000-00003","article-title":"Multiple sclerosis: Remyelination in acute lesions","volume":"52","author":"Raine","year":"1993","journal-title":"J Neuropathol Exp Neurol"},{"key":"2026010812432020800_awaf373-B25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2990.2007.00805.x","article-title":"Remyelination can be extensive in multiple sclerosis despite a long disease course","volume":"33","author":"Patani","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2026010812432020800_awaf373-B26","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.neuron.2022.09.023","article-title":"CNS remyelination and inflammation: From basic mechanisms to therapeutic opportunities","volume":"110","author":"Franklin","year":"2022","journal-title":"Neuron"},{"key":"2026010812432020800_awaf373-B27","doi-asserted-by":"crossref","first-page":"eaam7816","DOI":"10.1126\/scitranslmed.aam7816","article-title":"BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions","volume":"9","author":"Fard","year":"2017","journal-title":"Sci Transl Med"},{"key":"2026010812432020800_awaf373-B28","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ana.23693","article-title":"Cortical remyelination: A new target for repair therapies in multiple sclerosis","volume":"72","author":"Chang","year":"2012","journal-title":"Ann Neurol"},{"key":"2026010812432020800_awaf373-B29","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41586-018-0842-3","article-title":"Dynamics of oligodendrocyte generation in multiple sclerosis","volume":"566","author":"Yeung","year":"2019","journal-title":"Nature"},{"key":"2026010812432020800_awaf373-B30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00401-025-02868-5","article-title":"Impaired remyelination in late-onset multiple sclerosis","volume":"149","author":"Stork","year":"2025","journal-title":"Acta Neuropathol"},{"key":"2026010812432020800_awaf373-B31","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.neuron.2023.03.031","article-title":"Remyelination by surviving oligodendrocytes is inefficient in the inflamed mammalian cortex","volume":"111","author":"Mezydlo","year":"2023","journal-title":"Neuron"},{"key":"2026010812432020800_awaf373-B32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcdb.2020.09.009","article-title":"Revisiting remyelination: Towards a consensus on the regeneration of CNS myelin","volume":"116","author":"Franklin","year":"2021","journal-title":"Semin Cell Dev Biol."},{"key":"2026010812432020800_awaf373-B33","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1093\/brain\/awq250","article-title":"Demyelination versus remyelination in progressive multiple sclerosis","volume":"133","author":"Bramow","year":"2010","journal-title":"Brain"},{"key":"2026010812432020800_awaf373-B34","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1177\/13524585231204122","article-title":"Biological aging in multiple sclerosis","volume":"29","author":"Zhang","year":"2023","journal-title":"Mult Scler"},{"key":"2026010812432020800_awaf373-B35","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1073\/pnas.1818348116","article-title":"Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis","volume":"116","author":"Nicaise","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026010812432020800_awaf373-B36","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archneur.60.8.1073","article-title":"Remyelinated lesions in multiple sclerosis: Magnetic resonance image appearance","volume":"60","author":"Barkhof","year":"2003","journal-title":"Arch Neurol"},{"key":"2026010812432020800_awaf373-B37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/brain\/121.1.3","article-title":"The role of magnetic resonance techniques in understanding and managing multiple sclerosis","volume":"121","author":"Miller","year":"1998","journal-title":"Brain"},{"key":"2026010812432020800_awaf373-B38","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/ana.1053","article-title":"A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions","volume":"49","author":"Bitsch","year":"2001","journal-title":"Ann Neurol"},{"key":"2026010812432020800_awaf373-B39","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/WNL.50.5.1282","article-title":"Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis","volume":"50","author":"van Walderveen","year":"1998","journal-title":"Neurology"},{"key":"2026010812432020800_awaf373-B40","doi-asserted-by":"crossref","first-page":"117744","DOI":"10.1016\/j.neuroimage.2021.117744","article-title":"Can MRI measure myelin? Systematic review, qualitative assessment, and meta-analysis of studies validating microstructural imaging with myelin histology","volume":"230","author":"Lazari","year":"2021","journal-title":"Neuroimage"},{"key":"2026010812432020800_awaf373-B41","doi-asserted-by":"crossref","first-page":"117561","DOI":"10.1016\/j.neuroimage.2020.117561","article-title":"Myelin quantification with MRI: A systematic review of accuracy and reproducibility","volume":"226","author":"van der Weijden","year":"2021","journal-title":"NeuroImage"},{"key":"2026010812432020800_awaf373-B42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41598-020-79540-3","article-title":"An atlas for human brain myelin content throughout the adult life span","volume":"11","author":"Dvorak","year":"2021","journal-title":"Sci Rep"},{"key":"2026010812432020800_awaf373-B43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/mrm.1910310614","article-title":"In vivo visualization of myelin water in brain by magnetic resonance","volume":"31","author":"MacKay","year":"1994","journal-title":"Magn Reson Med"},{"key":"2026010812432020800_awaf373-B44","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.neuroimage.2007.12.008","article-title":"Myelin water imaging of multiple sclerosis at 7 T: Correlations with histopathology","volume":"40","author":"Laule","year":"2008","journal-title":"NeuroImage"},{"key":"2026010812432020800_awaf373-B45","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/bpa.12645","article-title":"Myelin water imaging to detect demyelination and remyelination and its validation in pathology","volume":"28","author":"Laule","year":"2018","journal-title":"Brain Pathol"},{"key":"2026010812432020800_awaf373-B46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/0470869526.ch8","volume-title":"Quantitative MRI of the brain","author":"Tofts","year":"2003"},{"key":"2026010812432020800_awaf373-B47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-510X(00)00331-2","article-title":"In vivo evaluation of remyelination in rat brain by magnetization transfer imaging","volume":"178","author":"Deloire-Grassin","year":"2000","journal-title":"J Neurol Sci"},{"key":"2026010812432020800_awaf373-B48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1148\/radiology.182.2.1732968","article-title":"Experimental allergic encephalomyelitis and multiple sclerosis: Lesion characterization with magnetization transfer imaging","volume":"182","author":"Dousset","year":"1992","journal-title":"Radiology"},{"key":"2026010812432020800_awaf373-B49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/nbm.3253","article-title":"In vivo quantitative magnetization transfer imaging correlates with histology during de- and remyelination in cuprizone-treated mice","volume":"28","author":"Turati","year":"2015","journal-title":"NMR Biomed"},{"key":"2026010812432020800_awaf373-B50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/nbm.972","article-title":"Multicontrast MRI of remyelination in the central nervous system","volume":"18","author":"Merkler","year":"2005","journal-title":"NMR Biomed"},{"key":"2026010812432020800_awaf373-B51","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.20202","article-title":"Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain","volume":"56","author":"Schmierer","year":"2004","journal-title":"Ann Neurol"},{"key":"2026010812432020800_awaf373-B52","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/mrm.21487","article-title":"Quantitative magnetic resonance of post mortem multiple sclerosis brain before and after fixation","volume":"59","author":"Schmierer","year":"2008","journal-title":"Magn Reson Med"},{"key":"2026010812432020800_awaf373-B53","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1177\/0271678X221107953","article-title":"Diffusion-derived parameters in lesions, peri-lesion and normal-appearing white matter in multiple sclerosis using tensor, kurtosis and fixel-based analysis","volume":"42","author":"van der Weijden","year":"2022","journal-title":"J Cereb Blood Flow Metab"},{"key":"2026010812432020800_awaf373-B54","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/jmrb.1996.0086","article-title":"Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI","volume":"111","author":"Basser","year":"1996","journal-title":"J Magn Reson B"},{"key":"2026010812432020800_awaf373-B55","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuroimage.2006.12.010","article-title":"Diffusion tensor imaging of post mortem multiple sclerosis brain","volume":"35","author":"Schmierer","year":"2007","journal-title":"Neuroimage"},{"key":"2026010812432020800_awaf373-B56","doi-asserted-by":"crossref","first-page":"118417","DOI":"10.1016\/j.neuroimage.2021.118417","article-title":"Fixel-based analysis of diffusion MRI: Methods, applications, challenges and opportunities","volume":"241","author":"Dhollander","year":"2021","journal-title":"NeuroImage"},{"key":"2026010812432020800_awaf373-B57","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3174\/ajnr.A6862","article-title":"Neurite orientation dispersion and density imaging for assessing acute inflammation and lesion evolution in MS","volume":"41","author":"Sacco","year":"2020","journal-title":"AJNR Am J Neuroradiol"},{"key":"2026010812432020800_awaf373-B58","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neuroimage.2015.05.023","article-title":"In vivo histology of the myelin g-ratio with magnetic resonance imaging","volume":"118","author":"Stikov","year":"2015","journal-title":"NeuroImage"},{"key":"2026010812432020800_awaf373-B59","doi-asserted-by":"crossref","first-page":"fcab249","DOI":"10.1093\/braincomms\/fcab249","article-title":"MRI-derived g-ratio and lesion severity in newly diagnosed multiple sclerosis","volume":"3","author":"York","year":"2021","journal-title":"Brain Commun."},{"key":"2026010812432020800_awaf373-B60","doi-asserted-by":"crossref","first-page":"108990","DOI":"10.1016\/j.jneumeth.2020.108990","article-title":"Towards in vivo g-ratio mapping using MRI: Unifying myelin and diffusion imaging","volume":"348","author":"Mohammadi","year":"2021","journal-title":"J Neurosci Methods"},{"key":"2026010812432020800_awaf373-B61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuroimage.2016.08.047","article-title":"Adult age differences in subcortical myelin content are consistent with protracted myelination and unrelated to diffusion tensor imaging indices","volume":"143","author":"Arshad","year":"2016","journal-title":"NeuroImage"},{"key":"2026010812432020800_awaf373-B62","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.mp.4001337","article-title":"Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins","volume":"8","author":"Flynn","year":"2003","journal-title":"Mol Psychiatry"},{"key":"2026010812432020800_awaf373-B63","doi-asserted-by":"crossref","first-page":"14991","DOI":"10.1038\/s41598-018-33112-8","article-title":"Age-related measurements of the myelin water fraction derived from 3D multi-echo GRASE reflect myelin content of the cerebral white matter","volume":"8","author":"Faizy","year":"2018","journal-title":"Sci Rep"},{"key":"2026010812432020800_awaf373-B64","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nicl.2014.09.003","article-title":"Magnetization transfer ratio recovery in new lesions decreases during adolescence in pediatric-onset multiple sclerosis patients","volume":"6","author":"Brown","year":"2014","journal-title":"Neuroimage Clin"},{"key":"2026010812432020800_awaf373-B65","doi-asserted-by":"crossref","first-page":"e85741","DOI":"10.1371\/journal.pone.0085741","article-title":"Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis","volume":"9","author":"Ghassemi","year":"2014","journal-title":"PLoS One"},{"key":"2026010812432020800_awaf373-B66","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ana.26441","article-title":"A new advanced MRI biomarker for remyelinated lesions in multiple sclerosis","volume":"92","author":"Rahmanzadeh","year":"2022","journal-title":"Ann Neurol."},{"key":"2026010812432020800_awaf373-B67","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/jon.13221","article-title":"Lesion phenotyping based on magnetic susceptibility in pediatric multiple sclerosis","volume":"34","author":"Boccia","year":"2024","journal-title":"J Neuroimaging."},{"key":"2026010812432020800_awaf373-B68","doi-asserted-by":"crossref","first-page":"e2217635120","DOI":"10.1073\/pnas.2217635120","article-title":"MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial","volume":"120","author":"Caverzasi","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026010812432020800_awaf373-B69","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1474-4422(21)00179-4","article-title":"Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR one): A randomised, double-blind, placebo-controlled, parallel-group, phase 2a study","volume":"20","author":"Brown","year":"2021","journal-title":"Lancet Neurol."},{"key":"2026010812432020800_awaf373-B70","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/acn3.51662","article-title":"Remyelination varies between and within lesions in multiple sclerosis following bexarotene","volume":"9","author":"Brown","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"2026010812432020800_awaf373-B71","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/acn3.51595","article-title":"Remyelination in humans due to a retinoid-X receptor agonist is age-dependent","volume":"9","author":"McMurran","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"2026010812432020800_awaf373-B72","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/brain\/awae024","article-title":"Time is myelin: Early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis","volume":"147","author":"Lazzarotto","year":"2024","journal-title":"Brain"},{"key":"2026010812432020800_awaf373-B73","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1172\/JCI86198","article-title":"Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions","volume":"126","author":"Absinta","year":"2016","journal-title":"J Clin Invest"},{"key":"2026010812432020800_awaf373-B74","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/ana.26194","article-title":"7T MRI differentiates remyelinated from demyelinated multiple sclerosis lesions","volume":"90","author":"Kolb","year":"2021","journal-title":"Ann Neurol"},{"key":"2026010812432020800_awaf373-B75","doi-asserted-by":"crossref","first-page":"118371","DOI":"10.1016\/j.neuroimage.2021.118371","article-title":"\u03c7-separation: Magnetic susceptibility source separation toward iron and myelin mapping in the brain","volume":"240","author":"Shin","year":"2021","journal-title":"NeuroImage"},{"key":"2026010812432020800_awaf373-B76","doi-asserted-by":"crossref","first-page":"e209604","DOI":"10.1212\/WNL.0000000000209604","article-title":"Quantifying remyelination using \u03c7-separation in white matter and cortical multiple sclerosis lesions","volume":"103","author":"M\u00fcller","year":"2024","journal-title":"Neurology"},{"key":"2026010812432020800_awaf373-B77","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/ana.24620","article-title":"Dynamic imaging of individual remyelination profiles in multiple sclerosis","volume":"79","author":"Bodini","year":"2016","journal-title":"Ann Neurol."},{"key":"2026010812432020800_awaf373-B78","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-bioeng-071114-040723","article-title":"Positron emission tomography: Current challenges and opportunities for technological advances in clinical and preclinical imaging systems","volume":"17","author":"Vaquero","year":"2015","journal-title":"Annu Rev Biomed Eng"},{"key":"2026010812432020800_awaf373-B79","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1007\/s00330-015-4202-5","article-title":"PET\/MRI of central nervous system: Current status and future perspective","volume":"26","author":"Yang","year":"2016","journal-title":"Eur Radiol"},{"key":"2026010812432020800_awaf373-B80","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.neuroimage.2019.05.042","article-title":"The influence of brain iron on myelin water imaging","volume":"199","author":"Birkl","year":"2019","journal-title":"NeuroImage"},{"key":"2026010812432020800_awaf373-B81","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jmri.25168","article-title":"Does hydration status affect MRI measures of brain volume or water content?","volume":"44","author":"Meyers","year":"2016","journal-title":"J Magn Reson Imaging."},{"key":"2026010812432020800_awaf373-B82","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/brain\/awn080","article-title":"Remyelination protects axons from demyelination-associated axon degeneration","volume":"131","author":"Irvine","year":"2008","journal-title":"Brain"},{"key":"2026010812432020800_awaf373-B83","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9440(10)64537-3","article-title":"Multiple sclerosis and chronic autoimmune encephalomyelitis","volume":"157","author":"Kornek","year":"2000","journal-title":"Am J Pathol"},{"key":"2026010812432020800_awaf373-B84","doi-asserted-by":"crossref","first-page":"e18246","DOI":"10.7554\/eLife.18246","article-title":"Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery","volume":"5","author":"Mei","year":"2016","journal-title":"Elife"},{"key":"2026010812432020800_awaf373-B85","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2377-14-58","article-title":"Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis","volume":"14","author":"Meyer-Moock","year":"2014","journal-title":"BMC Neurol"},{"key":"2026010812432020800_awaf373-B86","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/brain\/aww173","article-title":"Defining secondary progressive multiple sclerosis","volume":"139","author":"Lorscheider","year":"2016","journal-title":"Brain"},{"key":"2026010812432020800_awaf373-B87","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.24564","article-title":"Primary progressive multiple sclerosis evolving from radiologically isolated syndrome","volume":"79","author":"Kantarci","year":"2016","journal-title":"Ann Neurol"},{"key":"2026010812432020800_awaf373-B88","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1212\/01.wnl.0000256732.36565.4a","article-title":"Age at onset determines the occurrence of the progressive phase of multiple sclerosis","volume":"68","author":"Stankoff","year":"2007","journal-title":"Neurology"},{"key":"2026010812432020800_awaf373-B89","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamaneurol.2022.4655","article-title":"Association of early progression independent of relapse activity with long-term disability after a first demyelinating event in multiple sclerosis","volume":"80","author":"Tur","year":"2023","journal-title":"JAMA Neurol"},{"key":"2026010812432020800_awaf373-B90","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jns.2007.01.067","article-title":"Progression in multiple sclerosis: Further evidence of an age dependent process","volume":"255","author":"Koch","year":"2007","journal-title":"J Neurol Sci"},{"key":"2026010812432020800_awaf373-B91","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1212\/WNL.0b013e318230a17d","article-title":"Age and disability accumulation in multiple sclerosis","volume":"77","author":"Scalfari","year":"2011","journal-title":"Neurology"},{"key":"2026010812432020800_awaf373-B92","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/1352458512451510","article-title":"Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis","volume":"19","author":"Tutuncu","year":"2013","journal-title":"Mult Scler"},{"key":"2026010812432020800_awaf373-B93","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/brain\/awh714","article-title":"Age at disability milestones in multiple sclerosis","volume":"129","author":"Confavreux","year":"2006","journal-title":"Brain"},{"key":"2026010812432020800_awaf373-B94","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3390\/jcm9051326","article-title":"Clinical characteristics and disability progression of early- and late-onset multiple sclerosis compared to adult-onset multiple sclerosis","volume":"9","author":"Mirmosayyeb","year":"2020","journal-title":"J Clin Med"},{"key":"2026010812432020800_awaf373-B95","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa067597","article-title":"Natural history of multiple sclerosis with childhood onset","volume":"356","author":"Renoux","year":"2007","journal-title":"N Engl J Med."},{"key":"2026010812432020800_awaf373-B96","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/brain\/awaa199","article-title":"Improved relapse recovery in paediatric compared to adult multiple sclerosis","volume":"143","author":"Chitnis","year":"2020","journal-title":"Brain"},{"key":"2026010812432020800_awaf373-B97","doi-asserted-by":"crossref","first-page":"e2764","DOI":"10.1212\/WNL.0000000000007647","article-title":"Long-term disability progression of pediatric-onset multiple sclerosis","volume":"92","author":"McKay","year":"2019","journal-title":"Neurology"},{"key":"2026010812432020800_awaf373-B98","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1212\/WNL.0000000000001045","article-title":"Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth","volume":"83","author":"Aubert-Broche","year":"2014","journal-title":"Neurology"},{"key":"2026010812432020800_awaf373-B99","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/brainsci11040442","article-title":"Cognitive issues in pediatric multiple sclerosis","volume":"11","author":"Portaccio","year":"2021","journal-title":"Brain Sci"},{"key":"2026010812432020800_awaf373-B100","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1177\/1352458518800815","article-title":"Age is a critical determinant in recovery from multiple sclerosis relapses","volume":"25","author":"Conway","year":"2019","journal-title":"Mult Scler"},{"key":"2026010812432020800_awaf373-B101","doi-asserted-by":"crossref","first-page":"e000560","DOI":"10.1136\/bmjno-2023-000560","article-title":"Visual outcome measures in clinical trials of remyelinating drugs","volume":"6","author":"Riboni-Verri","year":"2024","journal-title":"BMJ Neurol Open"},{"key":"2026010812432020800_awaf373-B102","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1093\/brain\/awac207","article-title":"Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy","volume":"145","author":"Cordano","year":"2022","journal-title":"Brain"},{"key":"2026010812432020800_awaf373-B103","doi-asserted-by":"crossref","first-page":"27074","DOI":"10.1073\/pnas.1906358116","article-title":"Evoked potentials as a biomarker of remyelination","volume":"116","author":"Heidari","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026010812432020800_awaf373-B104","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1001\/archneur.1977.00500190037005","article-title":"Effects of aging on visual evoked responses","volume":"34","author":"Celesia","year":"1977","journal-title":"Arch Neurol"},{"key":"2026010812432020800_awaf373-B105","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0301-0082(93)90005-D","article-title":"EEG and event-related potentials in normal aging","volume":"41","author":"Dustman","year":"1993","journal-title":"Prog Neurobiol."},{"key":"2026010812432020800_awaf373-B106","doi-asserted-by":"crossref","first-page":"15671","DOI":"10.1038\/ncomms15671","article-title":"Age-related delay in visual and auditory evoked responses is mediated by white- and grey-matter differences","volume":"8","author":"Price","year":"2017","journal-title":"Nat Commun"},{"key":"2026010812432020800_awaf373-B107","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00006324-199503000-00007","article-title":"Aging and pattern visual evoked potentials","volume":"72","author":"Tobimatsu","year":"1995","journal-title":"Optom Vis Sci."},{"key":"2026010812432020800_awaf373-B108","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1093\/brain\/awac317","article-title":"The use of optical coherence tomography in neurology: A review","volume":"145","author":"Xie","year":"2022","journal-title":"Brain"},{"key":"2026010812432020800_awaf373-B109","doi-asserted-by":"crossref","first-page":"e1685","DOI":"10.1212\/WNL.0000000000200977","article-title":"Differences in age-related retinal and cortical atrophy rates in multiple sclerosis","volume":"99","author":"Cordano","year":"2022","journal-title":"Neurology"},{"key":"2026010812432020800_awaf373-B110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1474-4422(16)30377-5","article-title":"Safety and efficacy of opicinumab in acute optic neuritis (RENEW): A randomised, placebo-controlled, phase 2 trial","volume":"16","author":"Cadavid","year":"2017","journal-title":"Lancet Neurol."},{"key":"2026010812432020800_awaf373-B111","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/acn3.620","article-title":"Predictors of response to opicinumab in acute optic neuritis","volume":"5","author":"Cadavid","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"2026010812432020800_awaf373-B112","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): A randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"key":"2026010812432020800_awaf373-B113","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(22)00184-3","article-title":"Ageing and multiple sclerosis","volume":"22","author":"Graves","year":"2023","journal-title":"Lancet Neurol"},{"key":"2026010812432020800_awaf373-B114","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.aab3389","article-title":"Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection","volume":"350","author":"Blackburn","year":"2015","journal-title":"Science"},{"key":"2026010812432020800_awaf373-B115","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41576-018-0004-3","article-title":"DNA methylation-based biomarkers and the epigenetic clock theory of ageing","volume":"19","author":"Horvath","year":"2018","journal-title":"Nat Rev Genet"},{"key":"2026010812432020800_awaf373-B116","doi-asserted-by":"crossref","first-page":"926468","DOI":"10.3389\/fnagi.2022.926468","article-title":"Epigenetic clock indicates accelerated aging in glial cells of progressive multiple sclerosis patients","volume":"14","author":"Kular","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"2026010812432020800_awaf373-B117","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1212\/WNL.0000000000207489","article-title":"Evaluation of cell-specific epigenetic age acceleration in people with multiple sclerosis","volume":"101","author":"Maltby","year":"2023","journal-title":"Neurology"},{"key":"2026010812432020800_awaf373-B118","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2217\/epi-2019-0102","article-title":"Different epigenetic clocks reflect distinct pathophysiological features of multiple sclerosis","volume":"11","author":"Theodoropoulou","year":"2019","journal-title":"Epigenomics"},{"key":"2026010812432020800_awaf373-B119","doi-asserted-by":"crossref","first-page":"e213673","DOI":"10.1212\/WNL.0000000000213673","article-title":"Epigenetic aging in pediatric-onset multiple sclerosis","volume":"104","author":"Goyne","year":"2025","journal-title":"Neurology"},{"key":"2026010812432020800_awaf373-B120","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/ana.25592","article-title":"Telomere length is associated with disability progression in multiple sclerosis","volume":"86","author":"Krysko","year":"2019","journal-title":"Ann Neurol"},{"key":"2026010812432020800_awaf373-B121","doi-asserted-by":"crossref","first-page":"fcaf032","DOI":"10.1093\/braincomms\/fcaf032","article-title":"Exploratory analysis of biological age measures in a remyelination clinical trial","volume":"7","author":"McMurran","year":"2025","journal-title":"Brain Commun."}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awaf373\/64517711\/awaf373.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/149\/1\/48\/64517711\/awaf373.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/149\/1\/48\/64517711\/awaf373.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:43:56Z","timestamp":1767894236000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/149\/1\/48\/8275589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":121,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10,6]]},"published-print":{"date-parts":[[2026,1,8]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awaf373","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,10,6]]}}}